Achieve Life Sciences Inc (ACHV) has a current Price-to-Book (P/B) ratio of 7.81. Compared to its 3-year average P/B ratio of 25.76, the current P/B ratio is approximately -69.69% higher. Relative to its 5-year average P/B ratio of 17.46, the current P/B ratio is about -55.27% higher. Achieve Life Sciences Inc (ACHV) has a Forward Free Cash Flow (FCF) yield of approximately -15.37%. Compared to its 3-year average FCF yield of -25.28%, the current FCF yield is approximately -39.18% lower. Relative to its 5-year average FCF yield of -35.99%, the current FCF yield is about -57.28% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for ACHV competitors is 10.23, providing a benchmark for relative valuation. Achieve Life Sciences Inc Corp (ACHV.O) exhibits a P/S ratio of 50.72, which is 395.71% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of ACHV increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of ACHV in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is ACHV currently overvalued or undervalued?

What is Achieve Life Sciences Inc (ACHV) fair value?

ACHV's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Achieve Life Sciences Inc (ACHV) is between to according to relative valuation method.

How does ACHV's valuation metrics compare to the industry average?

The average P/S ratio for ACHV's competitors is 10.23, providing a benchmark for relative valuation. Achieve Life Sciences Inc Corp (ACHV) exhibits a P/S ratio of 50.72, which is 395.71% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for Achieve Life Sciences Inc (ACHV) as of Mar 04 2026?

As of Mar 04 2026, Achieve Life Sciences Inc (ACHV) has a P/B ratio of 7.81. This indicates that the market values ACHV at 7.81 times its book value.

What is the current FCF Yield for Achieve Life Sciences Inc (ACHV) as of Mar 04 2026?

As of Mar 04 2026, Achieve Life Sciences Inc (ACHV) has a FCF Yield of -15.37%. This means that for every dollar of Achieve Life Sciences Inc's market capitalization, the company generates -15.37 cents in free cash flow.

What is the current Forward P/E ratio for Achieve Life Sciences Inc (ACHV) as of Mar 04 2026?

As of Mar 04 2026, Achieve Life Sciences Inc (ACHV) has a Forward P/E ratio of -4.23. This means the market is willing to pay $-4.23 for every dollar of Achieve Life Sciences Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Achieve Life Sciences Inc (ACHV) as of Mar 04 2026?

As of Mar 04 2026, Achieve Life Sciences Inc (ACHV) has a Forward P/S ratio of 50.72. This means the market is valuing ACHV at $50.72 for every dollar of expected revenue over the next 12 months.

ACHV Valuation